2Weinstein G. Safety, efficacy and duration of therapeutic effect of tazarotene used in the treatment of plaque psoriasis [J]. Br J Dermatol, 1996,135:32-36 被引量：1
3Lebwohl MG,Breneman DL,Goffe BS,et al. Tazaroten 0.1% gel plus conticosteroid in the treatment of plaqut psoriasis [J]. Am Acad Dermatol, 1998,39:590-596 被引量：1
二级参考文献19
1[1]Disepio D,Malhotra M,Chandraratna RA,et al.Retinoic acid receptor-nuclear factorinterleukin 6 antagonism.A novel mechanism of retinoid-dependent inhibition of a keratinocyte hyperproliferative differentiation marker[J].J Bioel Chem,1997,272:2555 被引量：1
2[2]Duvic M,Nagpal S,Asano AT,ct al.Molecular mechanisms of tazarotene action in psoriasis[J].J Am Acad Dermatol,1997,37:s18～s24 被引量：1
3[3]Kashihara-Sawami M,Norris AD.The state of differentiation of cultured human keratinocytes determines the level of intercellular adhesion molecule1(ICAM-1) Expression induced by γ interferon[J].J Invest Dermatol,1992,98:741～747 被引量：1
6[6]Disepio D,Ghosn C,Eckert RL,et al.Identification and characterization of a retinoidinduced class Ⅱ tumor suppressor/growth regulatory gene[J].Proc Natl Acad Sci USA,1998,95:14811～14815 被引量：1
7[7]Virtanen M,Torma H,Vahlquist A.Keratin 4 upregulation by retinoic acid in vivo:A sensitive marker for retinoid bioactivity in human epidermis[J].J Invest Dermatol,2000,114:487～493 被引量：1
8[8]Tang-Liu DD,Matsumoto RM,Usansky JI.Clinical Pharmacokinetics and drug metabolism of tazarotene:a novel topical treatment for acne and psoriasis[J].Clin Pharmacokinet,1999,37:273～287 被引量：1
9[9]Marks R.Pharmacokinetics and safety review of tazarotene[J].J Am Acad Dermatol,1998,39:S134～138 被引量：1
10[10]Shalita AR,Chalker DK,Griffith RF,et al.Tazarotene gel is safe and effective in the treatment of acne vulgaris:a multicenter,double-blind,vehicle-controlled study [J].Cutis,1999,63:349～354 被引量：1
